Next 10 |
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...
Sydney, Australia (ABN Newswire) - On 5 April 2022, the Directors of VGI Health Technology Limited (NSX:VTL) announced the sale of its wholly owned subsidiary, Invictus BioPharma Pty Ltd to Invictus BioPharma Holdings Ltd (IVBHL) (the Transaction). Shareholders of VTL subsequently approved th...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into an R&D Loan Facility Agreement (Loan Facility) with Fundsquire Pty Ltd (Fundsquire). The Loan Facility allows up to 80% of VTL's expected R&D Tax Refund in FY23 t...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced dosing of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Stea...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received ethics approval to proceed with a US pharmacokinetics and exercise clinical study. Institutional Review Board (...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has made significant progress in its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic SteatoHe...
Sydney, Australia (ABN Newswire) - The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 June 2022. Status of Patent Ownership On 4 April 2022, VGI Health Technology Limited was pleased to announce that the the U...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced recruitment of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic...
News, Short Squeeze, Breakout and More Instantly...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...